10x Genomics TXG
$51.80 −$5.58 (-9.72%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $51.01 -1.53%
Open$55.77
Prev close$57.38
Day range$51.30 – $56.44
Volume3.23M
Market cap$6.81B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts13
Average target$76.27+47.2% vs. price
- Buy 38%
- Hold 62%
Low $60.00Now $51.80Avg $76.27High $110.00
Recent rating changes
The last 20 actions on file set price targets from $60.00 to $110.00, averaging $77.22.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 11 Nov 2026 | Stephens | HOLD | $65.00 |
| 9 Nov 2026 | UBS | HOLD | $61.00 |
| 9 Nov 2026 | Barclays | BUY | $70.00 |
| 9 Nov 2026 | J.P. Morgan | HOLD | $65.00 |
| 6 Nov 2026 | CCORF | BUY | $100.00 |
| 6 Nov 2026 | UBS | HOLD | $61.00 |
| 6 Nov 2026 | Piper Sandler | HOLD | $80.00 |
| 6 Nov 2026 | BofA Securities | HOLD | – |
| 6 Nov 2026 | Stifel | BUY | $68.00 |
| 6 Nov 2026 | Citi | HOLD | $60.00 |
| 6 Nov 2026 | Barclays | BUY | $70.00 |
| 5 Nov 2026 | RBC Capital | HOLD | $70.00 |
| 12 Oct 2026 | CCORF | BUY | $100.00 |
| 9 Oct 2026 | BofA Securities | HOLD | $80.00 |
| 7 Oct 2026 | Barclays | BUY | $110.00 |
| 29 Sep 2026 | William Blair | BUY | – |
| 29 Sep 2026 | Leerink Partners | HOLD | $90.00 |
| 25 Sep 2026 | Argus Research | BUY | $110.00 |
| 1 Sep 2026 | RBC Capital | HOLD | $70.00 |
| 10 Aug 2026 | CCORF | BUY | $60.00 |
No comments yet — be the first to weigh in on TXG.
Sign in to join the discussion.